BAYN.DE - Bayer AG
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $0.46
|
Rev Est: $11.3B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
Market Cap:
41.60B
Volume:
3,141,594
Avg Volume:
3,887,175
52 Week Range:
18.378-49.78
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.97
Last Dividend:
$0.11
Exchange:
XETRA
Country:
DE
Employees:
90,587
IPO Date:
1996-12-16
EPS (TTM):
-2.60
P/E Ratio:
-7.43
Revenue (TTM):
46.61B
Total Assets:
110.85B
Total Debt:
40.81B
Cash & Equiv:
6.19B
Rev Growth (5Y):
1.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-3.7%
ROCE:
-0.3%
Debt/Equity:
1.28
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $0.58 | $0.37 | +55.7% | $9.7B | $9.8B | -1.3% |
| 2025-08-06 | $1.24 | $0.91 | +36.6% | $10.7B | $10.9B | -1.2% |
| 2025-05-13 | $2.41 | $2.24 | +7.6% | $13.7B | $13.0B | +5.5% |
| 2025-03-05 | $1.01 | $0.94 | +7.3% | $11.7B | $10.8B | +8.5% |
| 2024-11-12 | $0.25 | $0.32 | -20.8% | $10.0B | $10.8B | -8.1% |
| 2024-08-06 | $0.94 | $0.88 | +6.8% | $11.1B | $10.8B | +3.4% |
| 2024-05-14 | $2.82 | $2.46 | +14.6% | $13.8B | $14.0B | -2.0% |
| 2024-03-05 | $1.85 | $1.47 | +25.9% | $11.9B | $11.9B | 0.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.61B | 47.64B | 50.74B | 44.08B | 41.40B | 43.55B | 39.59B | 35.02B | 46.77B | 46.32B | 42.24B | 40.16B |
| Net Income | (2.55B) | (2.94B) | 4.15B | 1.00B | (15.56B) | 2.43B | 1.70B | 7.34B | 4.53B | 4.11B | 3.43B | 3.19B |
| EPS | -2.60 | -2.99 | 4.22 | 1.02 | -15.84 | 2.48 | 1.80 | 8.29 | 5.44 | 4.97 | 4.14 | 3.86 |
| Total Assets | 110.85B | 116.26B | 124.88B | 120.24B | 117.05B | 126.26B | 126.28B | 75.09B | 82.24B | 73.92B | 70.23B | 51.32B |
| Total Debt | 40.81B | 44.79B | 41.65B | 39.53B | 41.55B | 38.88B | 40.67B | 13.21B | 18.26B | 18.80B | 19.24B | 7.20B |
| Cash & Equivalents | 6.19B | 5.91B | 5.17B | 4.56B | 4.19B | 3.19B | 4.05B | 7.58B | 1.90B | 1.86B | 1.85B | 1.66B |
| Operating Cash Flow | 7.37B | 5.12B | 7.09B | 5.09B | 4.90B | 8.21B | 7.92B | 8.13B | 9.09B | 6.89B | 5.81B | 5.17B |
| Free Cash Flow | 4.59B | 2.37B | 4.14B | 2.48B | 2.48B | 5.56B | 5.32B | 5.77B | 6.51B | 4.37B | 3.44B | 3.01B |
| FCF per Share | 4.67 | 2.41 | 4.22 | 2.52 | 2.53 | 5.66 | 5.66 | 6.61 | 7.82 | 5.29 | 4.16 | 3.64 |
| Book Value | 31.91B | 32.93B | 38.77B | 33.02B | 30.52B | 47.34B | 45.98B | 36.80B | 30.33B | 24.27B | 20.11B | 20.72B |
| Cash & ST Investments | 8.09B | 10.59B | 10.15B | 7.74B | 11.88B | 5.40B | 4.34B | 9.10B | 5.42B | 2.13B | 2.01B | 1.80B |
| ROC Equity | -0.08 | -0.09 | 0.11 | 0.03 | -0.51 | 0.05 | 0.04 | 0.20 | 0.15 | 0.17 | 0.17 | 0.15 |